Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

Samsung Biologics set a new earnings record last year, surpassing 5 trillion won ($3.59 billion) in cumulative orders for 2024 for the first time in the company’s history. Given the significance ...

Anirban holds a history degree from Jadavpur University and a post-graduate ... death in US 11:29 PM UTC · Updated ago Healthcare & Pharmaceuticalscategory China's WuXi Biologics to sell Irish vaccine ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...

WuXi Biologics' CEO Chris Chen has denied that the company’s sale of its less than four-year-old Ireland site is due to the threat of the US Biosecure Act, and said that the number of new ...

Its sister company WuXi Biologics rose 4.7%, while WuXi XDC, a contract medical research unit of WuXi Biologics, was up 5.0%. The WuXi companies have come under scrutiny amid tensions between the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SHANGHAI, Jan. 2, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...